Organization Announcements

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.

 

Paul G. Allen Frontiers Group [to 19 Jun 2021]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

 

BARDA – U.S. Department of HHS [to 19 Jun 2021]
https://www.phe.gov/about/barda/Pages/default.aspx
News
June 17, 2021: Biden Administration to Invest $3 Billion from American Rescue Plan as Part of COVID-19 Antiviral Development Strategy

 

BMGF – Gates Foundation [to 19 Jun 2021]
https://www.gatesfoundation.org/ideas/media-center
Press Releases and Statements
No new digest content identified.

 

Bill & Melinda Gates Medical Research Institute [to 19 Jun 2021]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
Jun 10, 2021
Penny Heaton @drpennyheaton
It’s a bittersweet day as I announce my departure from @GatesMRI to join @JanssenGlobal. I’m grateful for the opportunity to have led such an incredible organization – and I’m excited to lead a team transforming global #vaccine development.

 

CARB-X [to 19 Jun 2021]
https://carb-x.org/
News
No new digest content identified.

 

Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 19 Jun 2021]
https://centerforvaccineethicsandpolicy.net/
News/Analysis/Statements
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
:: [NEW] Informed Consent: A Monthly Review – June 2021 is now posted here

 

CEPI – Coalition for Epidemic Preparedness Innovations [to 19 Jun 2021]
http://cepi.net/
Latest News
EDCTP and CEPI funding moves IAVI’s Lassa fever vaccine candidate into advanced clinical development
14 Jun 2021

 

DARPA – Defense Advanced Research Projects Agency [to 19 Jun 2021
https://www.darpa.mil/news
News
No new digest content identified.

 

Duke Global Health Innovation Center [to 19 Jun 2021]
https://dukeghic.org/

WEEKLY COVID VACCINE RESEARCH UPDATE
Last dated update: FRIDAY, June 11, 2021

 

EDCTP [to 19 Jun 2021]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
15 June 2021
IAVI led consortium receives EDCTP and CEPI funding for a large-scale clinical trial of Lassa fever vaccine candidate

 

Emory Vaccine Center [to 19 Jun 2021]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.

 

European Vaccine Initiative [to 19 Jun 2021]
http://www.euvaccine.eu/
Latest News
No new digest content identified.

 

FDA [to 19 Jun 2021]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements /Selected Details
June 15, 2021 – Coronavirus (COVID-19) Update: June 15, 2021
:: Following our update on June 11 on the Emergent BioSolutions facility and the authorization  of certain batches of the Janssen COVID-19 vaccine drug substance, today the agency authorized the use, under the emergency use authorization (EUA) for the Janssen COVID-19 vaccine, of an additional batch of vaccine drug substance  manufactured at the Emergent facility. To date a total of three batches of Janssen drug substance that were manufactured at the Emergent facility have been authorized. The FDA conducted a thorough review of facility records and the results of quality testing performed by the manufacturer. Based on this review and considering the current COVID-19 public health emergency, the FDA has concluded that these batches are suitable for use. While the FDA is not yet ready to include the Emergent BioSolutions plant in the Janssen EUA as an authorized manufacturing facility, the agency continues to work through issues there with Janssen and Emergent BioSolutions management.
:: The FDA recently posted the updated translations for the Pfizer-BioNTech COVID-19 Vaccine Fact Sheet for Recipients and Caregivers in multiple languages. The translations can be found here.
:: The agency updated its FDA COVID-19 Response At-A-Glance Summary, which provides a quick look at facts, figures and highlights on the FDA’s response efforts.

 

Fondation Merieux [to 19 Jun 2021]
http://www.fondation-merieux.org/
News, Events
No new digest content identified

 

Gavi [to 19 Jun 2021]
https://www.gavi.org/
News Releases
18 June 2021
Republic of Korea pledges US$ 200 million to support lower-income economies through Gavi COVAX Advance Market Commitment

13 June 2021
G7 announces pledges of 870 million COVID-19 vaccine doses, of which at least half to be delivered by the end of 2021

Countries must share COVID-19 vaccine doses; the sooner the better
OPINION – by Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance
11 June 2021
[See COVID above for full text]

 

GHIT Fund [to 19 Jun 2021]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
No new digest content identified.

 

Global Fund [to 19 Jun 2021]
https://www.theglobalfund.org/en/news/
News & Stories
No new digest content identified

 

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 19 Jun 2021]
https://www.glopid-r.org/news/
News
No new digest content identified.

 

Hilleman Laboratories [to 19 Jun 2021]
http://www.hillemanlabs.org/
Website not responding at inquiry

 

Human Vaccines Project [to 19 Jun 2021]
http://www.humanvaccinesproject.org/
No new digest content identified.

 

IAVI [to 19 Jun 2021]
https://www.iavi.org/newsroom
Latest News
PRESS RELEASES
EDCTP and CEPI funding moves IAVI’s Lassa fever vaccine candidate into advanced clinical development
NEW YORK, THE HAGUE, AND OSLO – JUNE 15, 2021 – IAVI has received an award of €22.8 million from the European & Developing Countries Clinical Trials Partnership (EDCTP) and the Coalition for Epidemic Preparedness Innovations (CEPI) to conduct a Phase IIb clinical trial of a novel vaccine candidate to prevent Lassa fever disease. An acute viral illness endemic to many parts of West Africa, Lassa fever causes significant annual outbreaks of disease. There are an estimated 300,000 to 500,000 cases and 5,000 related deaths each year1. Despite this disease burden, which is believed to be significantly underestimated, no vaccine for Lassa fever is currently available.
The joint award supports an international collaboration, called Lassa Fever Vaccine Efficacy and Prevention for West Africa (LEAP4WA), to conduct a Phase IIb clinical trial of IAVI’s Lassa fever vaccine candidate among adults and children in Liberia, Nigeria, and Sierra Leone…

June 18, 2021
COVID-19 Vaccines in India: FAQs
Based on a Q&A with Dr. Gagandeep Kang, professor of microbiology at the Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences at the Christian Medical College in Vellore, India, held on May 12, 2021, and co-organized by IAVI and DBT/Wellcome Trust India Alliance.

 

 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 

ICRC [to 19 Jun 2021]
https://www.icrc.org/en/whats-new
Selected News Releases, Statements, Reports
How diverse leadership shaped responses to COVID-19 within the International Red Cross and Red Crescent Movement
The Humanitarian Advisory Group (HAG) in collaboration with the Global Network for Women Leaders in the Red Cross Red Crescent Movement (GLOW Red), the International Committee of the Red Cross (ICRC) and the International Federation of Red Cross and
16-06-2021 | Article

 

 

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

 

 

IFFIm
http://www.iffim.org/
Press Releases/Announcements
No new digest content identified.

 

IFRC [to 19 Jun 2021]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
Austria, Belgium, Europe, France, Netherlands
Red Cross Red Crescent sounds the alarm over deadly combination of heat and COVID-19
A looming heatwave in parts of Europe poses a deadly threat to the most vulnerable in our society, and action is urgently needed to protect them, said the IFRC.
18 June 2021

Bangladesh, Colombia, Turkey
Refugees are paying the highest price in the COVID-19 pandemic
Geneva, 18 June 2021 – Ahead of World Refugee Day on 20 June, the International Federation of Red Cross and Red Crescent Societies (IFRC) raises the alarm about the situation of refugees who are facing severe humanitarian hardships, which have been exa …
18 June 2021

Afghanistan
Afghanistan: COVID-19 at crisis point as hospitals overflow
Kuala Lumpur/Kabul/Geneva, 17 June 2021 – A COVID-19 surge in Afghanistan has reached a crisis point as infections and deaths are spiralling out of control, threatening to engulf the country’s fragile health system, as a consequence of decades of armed …
17 June 2021

Red Cross steps up support to Venezuelan migrants, including refugees, across 17 American countries
Panama City / Ottawa / Geneva, 15 June 2021 – To respond to the unmet needs of Venezuelan migrants, including refugees, living in Latin America and the Caribbean, the Red Cross Red Crescent Movement is strengthening its response to provide protection a …
15 June 2021

 

Institut Pasteur [to 19 Jun 2021]
https://www.pasteur.fr/en/press-area
Press Info
No new digest content identified.

 

IOM / International Organization for Migration [to 19 Jun 2021]
http://www.iom.int/press-room/press-releases
News
IOM and UNHCR Celebrate Commitment of the International Community to Mobilize Funds for Refugees and Migrants from Venezuela
2021-06-17 18:56
Ottawa – The International Organization for Migration (IOM) and UNHCR, the UN Refugee Agency, welcome the pledges made today, amounting to USD 1.5 billion, including USD 954 million in grants, during the International Donors’ Conference in Solidarity with Venezuelan Refugees and…

Making Migration Data Accessible for All
2021-06-15 17:06
Berlin – Timely and comprehensive migration statistics are essential for developing policies that benefit migrants, as well as their communities of origin and destination. The Global Migration Data Portal is unveiling today (15/06) its new dashboard featuring a series of tools…

IOM Ramps Up Health Response as Second Wave of COVID-19 Strikes Cox’s Bazar
2021-06-15 10:27
Cox’s Bazar – As a second wave of COVID-19 is ravaging South Asia, including Bangladesh, the International Organization for Migration (IOM) is working closely with the Government and the humanitarian community to ramp up the delivery of a wide range of support services for…

 

IRC International Rescue Committee [to 19 Jun 2021]
http://www.rescue.org/press-release-index
Media highlights [Selected]
Press Release
The IRC responds to UNHCR’s release today of global 2020 displacement figures
June 18, 2021

 

IVAC [to 19 Jun 2021]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
Webinar: Vaccines, Primary Care, and Public Health—After COVID, What’s Next?
When: Wednesday, July 7, 2021 from 12:00pm to 1:00pm ET
Join Dr. Tom Frieden, President and CEO of Resolve to Save Lives, for a 60-minute webinar hosted by the International Vaccine Access Center to discuss what roles and strategies vaccines, primary care and public health will play while we prepare for life after COVID-19.

 

IVI [to 19 Jun 2021]
http://www.ivi.int/
Selected IVI News, Announcements, Events
No new digest content identified.

 

JEE Alliance [to 19 Jun 2021]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

 

Johns Hopkins Center for Health Security [to 19 Jun 2021]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
No new digest content identified.

 

MSF/Médecins Sans Frontières [to 19 Jun 2021]
http://www.msf.org/
Latest [Selected Announcements
No new digest content identified.

 

National Academy of Medicine – USA [to 19 Jun 2021]
https://nam.edu/programs/
Selected News/Programs
National Academies Presidents Call For Allowing Scientific Evidence Determine the Origin of SARS-CoV-2
June 15, 2021 Statement
The origin of SARS-CoV-2, the virus that causes COVID-19, and the circumstances of the first cases of human infection, remain unknown.  Science is our best tool to ascertain, or to understand to the extent possible, the origins of SARS-CoV-2 and COVID-19, which could help prevent future pandemics.  However, misinformation, unsubstantiated claims, and personal attacks on scientists surrounding the different theories of how the virus emerged are unacceptable, and are sowing public confusion and risk undermining the public’s trust in science and scientists, including those still leading efforts to bring the pandemic under control.

 

We urge that investigations into the origins of SARS-CoV-2 and COVID-19 be guided by scientific principles, including reliance on verifiable data, reproducibility, objectivity, transparency, peer review, international collaboration, minimizing conflicts of interest, findings based on evidence, and clarity regarding uncertainties.  In the case of SARS-CoV-2, there are multiple scenarios that could, in principle, explain its origin with varying degrees of plausibility based on our current understanding.  These scenarios range from natural zoonotic spillover (when a virus spreads from non-human animals to humans) to those that are associated with laboratory work. Scientists need to be able to evaluate all of these scenarios, and all viable hypotheses, with credible data.  Data accessibility, transparency, and full cooperation from China, of course, will be essential for a proper and thorough investigation.

Although much still needs to be done to stop the pandemic, particularly in developing nations, science has made remarkable headway, especially through the rapid development of effective vaccines.  The same scientific robustness, rigor, and cooperation should be applied to examining important questions about how the pandemic began.

Marcia McNutt
President, National Academy of Sciences 

John L. Anderson
President, National Academy of Engineering 

Victor J. Dzau
President, National Academy of Medicine

 

National Vaccine Program Office – U.S. HHS [to 19 Jun 2021]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
NVAC 2021 Meetings
June 16-17, 2021 NVAC Meeting = Agenda

 

NIH [to 19 Jun 2021]
http://www.nih.gov/news-events/news-releases
News Releases
NIH study offers new evidence of early SARS-CoV-2 infections in U.S.
June 15, 2021 — Researchers analyze 24,000 blood samples and multiple antibody testing platforms to add to picture of COVID-19’s emergence.

U.S. clinical trial results show Novavax vaccine is safe and prevents COVID-19
June 14, 2021 — The investigational vaccine known as NVX-CoV2373 demonstrated 90.4% efficacy in preventing symptomatic COVID-19 disease.

 

UN OCHA Office for the Coordination of Humanitarian Affairs [to 19 Jun 2021]
https://www.unocha.org/
Press Releases
18 June 2021
United Nations launches the 2021 Venezuela Humanitarian Response Plan to assist 4.5 million people

14 June 2021
UN releases US$135 million for underfunded humanitarian crises

13 June 2021
United Nations Resident Coordinator and Humanitarian Coordinator in Syria, Imran Riza, and Regional Humanitarian Coordinator for the Syria Crisis, Muhannad Hadi – Joint Statement on Civilian Casualties in Afrin, Syria, 13 June 2021 [EN/AR]

13 June 2021
Joint UN Press Release – UN agencies in Sudan reach conflict-affected communities in non-government-controlled areas for first time in a decade [EN/AR]

 

PATH [to 19 Jun 2021]
https://www.path.org/media-center/
Press Releases
G7 Summit was a missed opportunity for action and funding needed to end COVID-19 pandemic
June 16, 2021 by PATH
[See G7 above for detail]

 

Rockefeller Foundation [to 19 Jun 2021]
https://www.rockefellerfoundation.org/
Selected Reports/Press Releases
Jun 15 2021
Press Releases
Ad Council, CDC Launch New Campaign Encouraging Americans to Mask Up Until You’re Vaccinated
June 15, 2021 | New York, NY – The Ad Council, in collaboration with the U.S. Centers for Disease Control and Prevention (CDC), today launched a series of public service …

Jun 14 2021
Press Releases
Scripps Research Collaborates with The Rockefeller Foundation on Digital Covid-19 Surveillance, Pandemic Preparedness
A grant from the New York-based foundation will fuel expansion of DETECT, Scripps Research’s sensor-based study for real-time digital detection of viral illness.     June 14, 2021, LA JOLLA, CA— Scientists

Jun 14 2021
Press Releases
The Rockefeller Foundation Welcomes the G7’s Commitment to Pandemic Prevention and the Carbis Bay Health Declaration to Stop the Next Pandemic in the First 100 Days
Statement from Dr. Rick Bright, Senior Vice -President, Pandemic Prevention and Response, The Rockefeller Foundation NEW YORK | June 14, 2021 – The Rockefeller Foundation looks forward to collaborating with the …

 

Sabin Vaccine Institute [to 19 Jun 2021]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.

 

UNAIDS [to 19 Jun 2021]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
15 June 2021
Listening to the voices of migrants living with HIV in the Russian Federation

14 June 2021
Global HIV Prevention Coalition reinforces the need for leadership and decisive action

14 June 2021
UNAIDS is deeply saddened by the death of Manuel da Quinta, a great professional and activist in the response to HIV and the promotion of human rights and equality

 

UNDP United Nations Development Programme [to 19 Jun 2021]
https://www.undp.org/news-centre
News Centre
Proposed global roadmap shows how universal access to sustainable energy can be achieved by 2030, transforming the lives of millions
Major commitments to be announced at Ministerial Forums on 21-25 June to accelerate access and transition to clean energy by 2030
Posted On June 18, 2021

 

UNHCR Office of the United Nations High Commissioner for Refugees [to 19 Jun 2021]
http://www.unhcr.org/en-us/media-centre.htmlS
Selected News Releases, Announcements
UNHCR: World leaders must act to reverse the trend of soaring displacement
18 Jun 2021

 

 

COVID-19 poses a major threat to the life and welfare of refugees in Uganda
17 Jun 2021

 

 

UNHCR and IOM celebrate the commitment of the international community to mobilize funds for refugees and migrants from Venezuela
Joint UNHCR/IOM press release
17 Jun 2021

 

UNICEF [to 19 Jun 2021]
https://www.unicef.org/media/press-releases
Selected Press Releases, Statements
Press release
06/17/2021
Affordable, quality childcare inaccessible in many of world’s wealthiest countries – UNICEF
According to a new UNICEF report, Luxembourg, Iceland, Sweden, Norway and Germany rank the highest on childcare provisions among 41 OECD and EU countries

Press release
06/13/2021
The ACT Accelerator partnership welcomes commitment of 870 million vaccine doses and calls for more investment in all tools to end the pandemic

Statement
06/13/2021
G7 announces pledges of 870 Million COVID-19 vaccine doses, of which at least half to be delivered by the end of 2021

Statement
06/13/2021
UNICEF welcomes G7 leaders’ commitments to donate COVID vaccine doses, calls for accelerated timetable
Statement by UNICEF Executive Director Henrietta Fore
[See COVAX above for detail]

 

Unitaid [to 19 Jun 2021]
https://unitaid.org/
Featured News
15 June 2021
Unprecedented cooperation with global oxygen suppliers paves way to increase access for low- and middle-income countries to address COVID-19 crisis
:: Agreement brokered by Unitaid and CHAI under the COVID-19 Oxygen Emergency Taskforce sees two of the world’s largest medical oxygen suppliers each collaborate with these ACT-Accelerator partners on increased access in low- and middle-income countries (LMICs)
:: Two memoranda of understanding, one with Air Liquide and another with Linde, pave the way for increased oxygen supply in the context of COVID-19
:: Latest estimates show that around 1 million COVID-19 patients in LMICs need 2.2 million cylinders of oxygen per day

 

Vaccination Acceptance & Demand Initiative [Sabin) [to 19 Jun 2021]
https://www.vaccineacceptance.org/
Announcements
No new digest content identified.

 

Vaccine Confidence Project [to 19 Jun 2021]
http://www.vaccineconfidence.org/
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).

 

Vaccine Education Center – Children’s Hospital of Philadelphia [to 19 Jun 2021]
http://www.chop.edu/centers-programs/vaccine-education-center
News
What Should I Know About COVID-19 Vaccine and Myocarditis in Teens?
Last Reviewed on Jun 14, 2021
Dr. Paul Offit discusses myocarditis, an inflammation of the heart muscle, related to receipt of the COVID-19 vaccine, and considerations related to the relative risks and benefits of vaccination compared with vulnerability to COVID-19.

 

Wellcome Trust [to 19 Jun 2021]
https://wellcome.ac.uk/news
News and reports
No new digest content identified.

 

The Wistar Institute [to 19 Jun 2021]
https://www.wistar.org/news/press-releases
Press Releases
No new digest content identified.

 

WFPHA: World Federation of Public Health Associations [to 19 Jun 2021]
https://www.wfpha.org/
Latest News
No new digest content identified.

 

World Bank [to 19 Jun 2021]
http://www.worldbank.org/en/news/all
Selected News, Announcements
Vaccinating Refugees: Lessons from the Inclusive Lebanon Vaccine Roll-Out Experience
Authors: Naila Ahmed, Nour Aoun, Noushig Kaloustian, Farah Asfahani, Ronald Eduardo Gomez Suarez, Sherin Varkey Countries hosting refugees in the Mashreq region face a daunting challenge. The Mashreq region…
Date: June 18, 2021 Type: Feature Story

Economic Crisis Pushes Many Workers into the Informal Labor Market in Latin America and the Caribbean
WASHINGTON, June 17, 2021 – Economic crises like the one that Latin America and the Caribbean is suffering now, have long-lasting effects on the structure of employment and may permanently drive many from…
Date: June 17, 2021 Type: Press Release

Indonesia: Rapid Mass Vaccination, Effective Pandemic Control and Strong Fiscal and Monetary Support are Critical to Boost the Economic Recovery.
Jakarta, June 17, 2021—Indonesia’s economy is projected to rebound from the 2020 recession with 4.4 percent growth in 2021. The rebound is predicated on the pandemic being contained and the global economy…
Date: June 17, 2021 Type: Press Release

World Bank-UNICEF Survey Finds Inequality Has Likely Increased in PNG, with Bottom 40% Hit Hardest by Latest Outbreak
Latest household survey shows that COVID-19 is exacerbating existing inequalities across PNG, with families in the bottom 40% in danger of being left behind. PORT MORESBY, June 17, 2020 – A joint World…
Date: June 17, 2021 Type: Press Release

World Bank Approves $20 Million in Grants to Support COVID-19 Vaccination Rollout in Yemen
WASHINGTON, June 17, 2021 — The World Bank today approved a US$20 million grant package. This package is composed of US$9 million from International Development Association (IDA), US$$7.76 million from…
Date: June 17, 2021 Type: Press Release

World Bank Approves $20 Million in Grants to Support COVID-19 Vaccination Rollout in Yemen
WASHINGTON, June 17, 2021 — The World Bank today approved a US$20 million grant package. This package is composed of US$9 million from International Development Association (IDA), US$$7.76 million from…
Date: June 17, 2021 Type: Press Release

World Bank, IMF Launch High-Level Advisory Group on Sustainable and Inclusive Recovery and Growth
WASHINGTON, June 15, 2021—In the face of two crises – COVID-19 and climate change – the World Bank Group and International Monetary Fund launched a High-Level Advisory Group (HLAG) on Sustainable and Inclusive…
Date: June 15, 2021 Type: Press Release

 

World Customs Organization – WCO [to 19 Jun 2021]
http://www.wcoomd.org/
Latest News – Selected Items
17 June 2021
Free zone experts of the North of Africa, North and Middle East Region discuss effective implementation of the WCO Practical Guidance on Free Zones

 

World Organisation for Animal Health (OIE) [to 19 Jun 2021]
https://www.oie.int/en/for-the-media/press-releases/2021/
Press Releases
No new digest content identified.

::::::

 

ARM [Alliance for Regenerative Medicine] [to 19 Jun 2021]
Press Releases – Alliance for Regenerative Medicine (alliancerm.org)
Selected Press Releases
No new digest content identified.

 

BIO [to 19 Jun 2021]
https://www.bio.org/press-releases
Press Releases
No new digest content identified.

 

DCVMN – Developing Country Vaccine Manufacturers Network [to 19 Jun 2021]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.

 

ICBA – International Council of Biotechnology Associations [to 19 Jun 2021]
https://internationalbiotech.org/news/
News
In a new digital film series, ICBA uncovers the stories of innovation using nature’s building blocks to change the world every day through biotechnology.
Jun. 16 2021
Produced by BBC StoryWorks Commercial Productions, this exploratory online video series uncovers the powerful stories of innovation in biotechnology across …

 

IFPMA [to 19 Jun 2021]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
Innovative biopharmaceutical industry welcomes the G7 agreement to work in partnership with the private sector
12 June 2021
The report presented to the G7 leaders ‘100 Days Mission for diagnostics, therapeutics and vaccines to respond to future pandemic threats’ today comes following discussions with CEOs and representatives of life science companies with Sir Patrick Vallance and Melinda French Gates at a UK-hosted G7 Health Ministers’ and life sciences meetings in Oxford on 3rd June to discuss the pandemic preparedness partnership roadmap.
At the 3 June meeting, the life science industry leaders agreed to join forces with governments to step up collective efforts to ensure the world is better prepared to tackle future global pandemics. The industry shares the belief that actions such as expanded vaccination programmes and use of diagnostics will strengthen innovation and health system capacities globally, and that improvements to essential regulatory and pathogen sharing mechanisms will make future responses more secure.
Innovative vaccine manufacturers and biotech companies who are at the forefront of the global effort to develop and manufacture COVID-19 vaccines and treatments have been instrumental in the world having safe and effective vaccines approved in 326 days. They have achieved a historic feat of scaling up manufacturing of COVID-19 vaccines from zero to 2,2 billion at the end of May, and an estimated 10 to 11 billion by the end of 2021, which should be enough to vaccinate the world’s adult population if shared equitably. They will share the hard learnt lessons from this pandemic and their scientific and manufacturing knowhow to the 100 Day Mission.
The collective aspiration to support the 100 Days Mission represents a significant milestone and requires sustained leadership, investment and effort from many stakeholders. It ensures industry is part of a robust collaboration alongside governments, international organisations and academia over the coming months and years to take action towards a common goal: protecting people from future pandemics through developing and deploying safe, targeted and effective diagnostics, therapeutics and vaccines at scale, with a good safety profile.
The G7 leaders decision is the starting point for partnership between industry and government to achieve this mission together…

 

PhRMA [to 19 Jun 2021]
http://www.phrma.org/
Latest News
No new digest content identified.

Journal Watch

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

Transgenerational Trauma

AMA Journal of Ethics
Volume 23, Number 6: E435-504 June 2021
https://journalofethics.ama-assn.org/issue/transgenerational-trauma

 

Transgenerational Trauma
One thing that makes trauma transgenerational is narrative. Narrative, for example, is what makes a Confederate flag from 1865 flint for insurrection in 2021. Consequences of global and domestic insults, such as slavery and forced migration, have long ramified intergenerationally in communities, families, and individuals’ bodies. Legacies of trauma travel in stories across places and over time, and their effects include health status inequity and cumulative stress embodiment. Transmission of historically entrenched patterns of oppression also influence persons’ lived experiences of marginalization, convey health risk, and can play out during clinical encounters.

Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19

Annals of Internal Medicine
June 2021 Volume 174, Issue 6
http://annals.org/aim/issue

 

Original Research
Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19
FREE
Shannon Wongvibulsin, PhD, Brian T. Garibaldi, MD, MEHP, Annukka A.R. Antar, MD, PhD, … et al.
Pages:777–785

Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19

Annals of Internal Medicine
June 2021 Volume 174, Issue 6
http://annals.org/aim/issue

 

Original Research
Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19
FREE
Shannon Wongvibulsin, PhD, Brian T. Garibaldi, MD, MEHP, Annukka A.R. Antar, MD, PhD, … et al.
Pages:777–785

Elusive quality: the challenges and ethical dilemmas faced by international non-governmental organisations in sourcing quality assured medical products

BMJ Global Health
May 2021 – Volume 6 – Suppl 3
https://gh.bmj.com/content/6/Suppl_3

 

Social and ethical issues of poor quality and poor use of medical products
Practice
Elusive quality: the challenges and ethical dilemmas faced by international non-governmental organisations in sourcing quality assured medical products (28 May, 2021)
Katherine Enright

Advancing discussion of ethics in mixed methods health services research

BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 19 Jun 2021)

 

Advancing discussion of ethics in mixed methods health services research
To describe the ethical issues and experiences of scientists conducting mixed methods health services research and to advance empirical and conceptual discussion on ethical integrity in mixed methods health research… Mixed methods health researchers reported encountering ethical issues often yet varying levels of difficulty and effectiveness in the strategies used to mitigate ethical issues. This study highlights some of the unique challenges faced by mixed methods researchers to plan for and appropriately respond to arising ethical issues such as managing participant burden and confidentiality across data sources and utilizing effective communication and dissemination strategies particularly when working with a multidisciplinary research team. As one of the first empirical studies to examine mixed methods research ethics, our findings highlight the need for greater attention to ethics in health services mixed methods research and training.
Authors: Nicole A. Stadnick, Cheryl N. Poth, Timothy C. Guetterman and Joseph J. Gallo
Citation: BMC Health Services Research 2021 21:577
Content type: Research
Published on: 15 June 2021

Hospital-based prospective study of pertussis in infants and close contacts in Tehran, Iran

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 19 Jun 2021)

 

Hospital-based prospective study of pertussis in infants and close contacts in Tehran, Iran
Pertussis remain a global health concern, especially in infants too young to initiate their vaccination. Effective vaccination and high coverage limit the circulation of the pathogen, yet duration of protectio…
Authors: Gaelle Noel, Masoumeh Nakhost Lotfi, Sajedeh Mirshahvalad, Sedaghatpour Mahdi, David Tavel, Seyed M. Zahraei, Roxana Mansour Ghanaie, Tahereh Heidary, Aliahmad Goudarzi, Azardokht Kazemi, Abdollah Karimi, Alireza Nateghian, Mohand Ait-Ahmed, Nicole Guiso, Fereshteh Shahcheraghi and Fabien Taieb
Citation: BMC Infectious Diseases 2021 21:586
Content type: Research
Published on: 18 June 2021

Vaccine completion and infectious diseases screening in a cohort of adult refugees following resettlement in the U.S.: 2013–2015

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 19 Jun 2021)

 

Vaccine completion and infectious diseases screening in a cohort of adult refugees following resettlement in the U.S.: 2013–2015
Refugees are frequently not immune to vaccine-preventable infections. Adherence to consensus guidelines on vaccination and infectious diseases screening among refugees resettling in the U.S. is unknown. We sou…
Authors: Amir M. Mohareb, Bryan Brown, Kevin S. Ikuta, Emily P. Hyle and Aniyizhai Annamalai
Citation: BMC Infectious Diseases 2021 21:582
Content type: Research
Published on: 16 June 2021

Moral distress and ethical climate in intensive care medicine during COVID-19: a nationwide study

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 19 Jun 2021)

 

Moral distress and ethical climate in intensive care medicine during COVID-19: a nationwide study
Authors: Moniek A. Donkers, Vincent J. H. S. Gilissen, Math J. J. M. Candel, Nathalie M. van Dijk, Hans Kling, Ruth Heijnen-Panis, Elien Pragt, Iwan van der Horst, Sebastiaan A. Pronk and Walther N. K. A. van Mook
Content type: Research
17 June 2021

Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 19 Jun 2021)

 

Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout
As in many countries, quantifying COVID-19 spread in Indonesia remains challenging due to testing limitations. In Java, non-pharmaceutical interventions (NPIs) were implemented throughout 2020. However, as a v…
Authors: Bimandra A. Djaafara, Charles Whittaker, Oliver J. Watson, Robert Verity, Nicholas F. Brazeau, Widyastuti, Dwi Oktavia, Verry Adrian, Ngabila Salama, Sangeeta Bhatia, Pierre Nouvellet, Ellie Sherrard-Smith, Thomas S. Churcher, Henry Surendra, Rosa N. Lina, Lenny L. Ekawati…
Citation: BMC Medicine 2021 19:146
Content type: Research article
Published on: 18 June 2021

“Saint Google, now we have information!”: a qualitative study on narratives of trust and attitudes towards maternal vaccination in Mexico City and Toluca

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 19 Jun 2021)

 

“Saint Google, now we have information!”: a qualitative study on narratives of trust and attitudes towards maternal vaccination in Mexico City and Toluca
Maternal vaccination is key to decreasing maternal and infant mortality globally. Yet perceptions about maternal vaccines and immunization among pregnant women are often understudied, particularly in low- and …
Authors: Clarissa Simas, Heidi J. Larson and Pauline Paterson
Citation: BMC Public Health 2021 21:1170
Content type: Research
Published on: 18 June 2021

Structural inequities in seasonal influenza vaccination rates

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 19 Jun 2021)

 

Structural inequities in seasonal influenza vaccination rates
Influenza immunization is a highly effective method of reducing illness, hospitalization and mortality from this disease. However, influenza vaccination rates in the U.S. remain below public health targets and…
Authors: Lara I. Brewer, Mark J. Ommerborn, Augustina Le Nguyen and Cheryl R. Clark
Citation: BMC Public Health 2021 21:1166
Content type: Research
Published on: 17 June 2021

The protection motivation theory for predict intention of COVID-19 vaccination in Iran: a structural equation modeling approach

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 19 Jun 2021)

 

The protection motivation theory for predict intention of COVID-19 vaccination in Iran: a structural equation modeling approach
Many efforts are being made around the world to discover the vaccine against COVID-19. After discovering the vaccine, its acceptance by individuals is a fundamental issue for disease control. This study aimed …
Authors: Alireza Ansari-Moghaddam, Maryam Seraji, Zahra Sharafi, Mahdi Mohammadi and Hassan Okati-Aliabad
Citation: BMC Public Health 2021 21:1165
Content type: Research
Published on: 17 June 2021

Development of a theory-based HPV vaccine promotion comic book for East African adolescents in the US

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 19 Jun 2021)

 

Development of a theory-based HPV vaccine promotion comic book for East African adolescents in the US
Human Papillomavirus (HPV) vaccine uptake is low among East African adolescents in the US. Adolescents’ preferences influence HPV vaccine decisions, yet few interventions exist that address East African adoles…
Authors: Isabelle Celentano, Rachel L. Winer, Sou Hyun Jang, Anisa Ibrahim, Farah Bille Mohamed, John Lin, Fanaye Amsalu, Ahmed A. Ali, Victoria M. Taylor and Linda K. Ko
Citation: BMC Public Health 2021 21:1137
Content type: Research article
Published on: 14 June 2021

Politics of Vaccine Nationalism in India: Global and Domestic Implications

Forum for Development Studies
Volume 48, 2021 – Issue 2
http://www.tandfonline.com/toc/sfds20/current

 

Article
Politics of Vaccine Nationalism in India: Global and Domestic Implications
Niladri Chatterjee, Zaad Mahmood & Eleonor Marcussen
Pages: 357-369
Published online: 09 May 2021
Abstract
The fight against the Covid-19 pandemic has shifted from finding a cure to acquiring vaccines and organizing vaccination. The race for vaccination has exacerbated tendencies of hoarding, particularly among rich countries, academically expressed as vaccine nationalism. Vaccine nationalism is harmful to the global effort in the fight against the pandemic. India in contrast has been quite generous to its neighbours in sharing vaccines pursuing its own form of vaccine nationalism. The strategy pursued by India can be read as an effort to gloss over the failures in initial pandemic management, to improve diplomatic leverage and reinforce an idiom of nationalism. Such an effort however has potentially harmful effects undermining trust in the vaccine as well as in the government. The politicization of vaccine also has counterproductive outcomes for democratic practices within the country.

Landscape and selection of vaccine epitopes in SARS-CoV-2

Genome Medicine
https://genomemedicine.biomedcentral.com/articles
[Accessed 19 Jun 2021]

 

Landscape and selection of vaccine epitopes in SARS-CoV-2
Early in the pandemic, we designed a SARS-CoV-2 peptide vaccine containing epitope regions optimized for concurrent B cell, CD4+ T cell, and CD8+ T cell stimulation. The rationale for this design was to drive bot…
Authors: Christof C. Smith, Kelly S. Olsen, Kaylee M. Gentry, Maria Sambade, Wolfgang Beck, Jason Garness, Sarah Entwistle, Caryn Willis, Steven Vensko, Allison Woods, Misha Fini, Brandon Carpenter, Eric Routh, Julia Kodysh, Timothy O’Donnell, Carsten Haber…
Citation: Genome Medicine 2021 13:101
Content type: Research
Published on: 14 June 2021

A cross-country comparison of malaria policy as a premise for contextualized appropriation of foreign aid in global health

Health Research Policy and Systems
http://www.health-policy-systems.com/content
[Accessed 19 Jun 2021]

 

A cross-country comparison of malaria policy as a premise for contextualized appropriation of foreign aid in global health
Foreign aid continues to play an essential role in health sector development in low-resource countries, particularly in terms of providing a vital portion of their health expenditures. However, the relationshi…
Authors: Tomas Jezek and Oluwaseun Adebayo Bamodu
Citation: Health Research Policy and Systems 2021 19:93
Content type: Research
Published on: 14 June 2021

Primum Non Nocere: Should Gene Therapy Be Used to Prevent Potentially Fatal Disease but Enable Potentially Destructive Behavior?

Human Gene Therapy
Volume 32, Issue 11-12 / June 2021
https://www.liebertpub.com/toc/hum/32/11-12

 

Commentary
Primum Non Nocere: Should Gene Therapy Be Used to Prevent Potentially Fatal Disease but Enable Potentially Destructive Behavior?
Inmaculada de Melo-Martin and Ronald G. Crystal
Pages:529–534
Published Online:26 April 2021
https://doi.org/10.1089/hum.2021.039

Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination

Human Gene Therapy
Volume 32, Issue 11-12 / June 2021
https://www.liebertpub.com/toc/hum/32/11-12

 

Review Free
Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination
Atil Bisgin, Ahter D. Sanlioglu, Yunus Emre Eksi, Thomas S. Griffith, and Salih Sanlioglu
Pages:541–562
Published Online:29 April 2021
https://doi.org/10.1089/hum.2021.052

Localisation and local humanitarian action

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/inclusion-of-persons-with-disabilities-in-humanitarian-action-what-now/

 

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

World Meningitis Day and the World Health Organization’s roadmap to defeat bacterial meningitis in the COVID-19 pandemic era

International Journal of Infectious Diseases
Volume 107 p1-310
https://www.ijidonline.com/current

 

Editorials
World Meningitis Day and the World Health Organization’s roadmap to defeat bacterial meningitis in the COVID-19 pandemic era
Tatiana Castro Abreu Pinto, Natalia Silva Costa, Laura Maria Andrade Oliveira
Published online: April 28, 2021
p219-220

Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

JAMA
June 15, 2021, Vol 325, No. 23, Pages 2327-2410
https://jamanetwork.com/journals/jama/currentissue

 

Original Investigation
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women
Ai-ris Y. Collier, MD; Katherine McMahan, MS; Jingyou Yu, PhD; et al.
free access has active quiz
JAMA. 2021;325(23):2370-2380. doi:10.1001/jama.2021.7563
This study assesses the immunogenicity of the current COVID-19 mRNA vaccines in pregnant and lactating women against both the original SARS-CoV-2 USA-WA1/2020 strain as well as against the B.1.1.7 and B.1.351 variants of concern.

Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021

JAMA
June 15, 2021, Vol 325, No. 23, Pages 2327-2410
https://jamanetwork.com/journals/jama/currentissue

 

Research Letter
Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021
Michael Daly, PhD; Andrew Jones, PhD; Eric Robinson, PhD
free access
JAMA. 2021;325(23):2397-2399. doi:10.1001/jama.2021.8246
This online survey study of US adults characterizes trends in coronavirus vaccine hesitancy and public trust in vaccination before and after COVID-19 vaccine availability in the US.

Restoring Vaccine Diplomacy

JAMA
June 15, 2021, Vol 325, No. 23, Pages 2327-2410
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
Restoring Vaccine Diplomacy
Peter J. Hotez, MD, PhD; K. M. Venkat Narayan, MD
free access has active quiz
JAMA. 2021;325(23):2337-2338. doi:10.1001/jama.2021.7439
This Viewpoint discusses the importance of equitable international collaboration, innovative manufacturing and supply chain development, and shared governance to provide the billions of COVID-19 vaccine doses to the world’s low-income and low-resource populations that will be necessary to control the coronavirus pandemic.

Overview of the Issue

Journal of Health Care for the Poor and Underserved (JHCPU)
Volume 32, Number 2, May 2021 Supplement
https://muse.jhu.edu/issue/44396

 

Table of Contents
Overview of the Issue
Kevin B. Johnson, Tiffani J. Bright, Cheryl R. Clark
…The importance of techquity—defined as the strategic development and deployment of technology in health care and health to advance health equity—was even more apparent after the events of 2020. COVID-19 upended access to care and illuminated the impact of structural racism as a cause for a widening gap of access during the pandemic. Black Lives Matter became more than a trending hashtag on Twitter, or a movement resulting in peaceful protests and calls for policy reform: it put additional focus on the issue of race as a social and not a biological construct and called into question the rationale for common practices in health care that were triggered by race. A notable example was the emerging realization that kidney function assessment was tied to race and hardwired into many of our electronic health records. The real-world evidence around our lack of techquity was incontrovertible.
This Supplemental Issue of JHCPU provides articles that describe challenges to techquity, frameworks to improve the role of technology in care, and examples of how technology can transform health, public health, and health care…

The Wrong Cure: Financial Incentives for Unimpressive New Antibiotics

Journal of Infectious Diseases
Volume 223, Issue 9, 1 May 2021
https://academic.oup.com/jid/issue/223/9

 

BACTERIA
The Wrong Cure: Financial Incentives for Unimpressive New Antibiotics
Michael S Sinha, John H Powers, III, Aaron S Kesselheim
The Journal of Infectious Diseases, Volume 223, Issue 9, 1 May 2021, Pages 1506–1509, https://doi.org/10.1093/infdis/jiaa536
Though antimicrobial resistance is a public health concern, the basis of approval for many new antibiotics does not distinguish them from older products. We suggest a more tailored incentive structure for antibiotic development, focused on clinical benefit and patient outcomes.

Protecting refugees during the COVID-19 pandemic

The Lancet
Jun 19, 2021 Volume 397 Number 10292 p2309-2438, e16
https://www.thelancet.com/journals/lancet/issue/current

 

Editorial
Protecting refugees during the COVID-19 pandemic
The Lancet
his World Refugee Day, June 20, coincides with 70 years of the 1951 Refugee Convention, a multilateral treaty that shaped the standards that provide the bedrock of international protection for refugees against discrimination and violation of their human rights. The COVID-19 pandemic has weighed heavily on the 26·3 million refugees worldwide today. International guidelines and national programmes to curb transmission have not always considered the needs of refugees living in densely populated shelters without water and sanitation facilities. The economic harms of the pandemic disproportionately affect the poorest people, applications for asylum and resettlement were disrupted by lockdowns, and refugees have been blamed for spreading SARS-CoV-2. It is timely to consider whether the spirit of the Refugee Convention is being upheld and whether refugees are getting the protection to which they are entitled.

Vaccination is the central pillar of global recovery from the COVID-19 pandemic, but most refugees face a double burden of vaccine inequity. First, 86% of refugees live in low-income and middle-income countries (LMICs), which are heavily reliant on COVAX, an initiative set up to ensure equitable access to COVID-19 vaccines and built on principles of solidarity. But as a World Report in this issue explains, weaknesses in design and selfish political motivations have led to the failure of this vision. As of June 14, only 87 million doses have been shipped to 131 countries through COVAX, far below targets. Second, many LMICs that have received vaccines are not prioritising refugees. For example, in Bangladesh, where 2·5% of the population is fully vaccinated, not a single dose has been administered in Cox’s Bazar. In the world’s largest refugee camp, non-pharmaceutical measures remain the sole tool to prevent major outbreaks.

A report by the ECDC shows how even in high-income countries with advanced immunisation programmes that include (and in some cases prioritise) refugees, barriers to care and vaccination still exist. Uptake of vaccination is low, and the report presents evidence that vaccine acceptance in European migrant populations is undermined by communication challenges, discrimination and stigma, fear of deportation, and a loss of trust in authorities. These issues partly explain why refugees and asylum seekers more generally have suboptimal access to primary health-care services in the region. Language barriers contribute to a deficit of accurate information, and social marginalisation has allowed misinformation to spread, fuelling vaccine hesitancy. Engaging with refugee communities to understand their concerns and studying barriers to vaccination will be essential for protecting all.

Indeed, there is no shortage of research needs in studies of refugees, migration, and health. To this end, building on the recommendations of the UCL–Lancet Commission on Migration and Health, the Lancet Migration European Regional Hub launches on June 22, to fill a major gap in pan-European migration and health research initiatives. It will address research needs, foster collaboration, and bring evidence-based approaches to public discourse and policy around migration and health.

But addressing these issues is not simply a matter of acquiring more and better evidence. Political and moral discussions about migration and refugees are taking place too. All countries, including wealthy ones, have suffered grievously because of COVID-19. Millions of people have died, health systems have been overwhelmed, and economies have been shattered. A wish to turn inward at such a moment is understandable. Even US Vice-President Kamala Harris warned would-be Guatemalan migrants not to come to the USA earlier this month. How can a broken nation look beyond its own citizens? And how do we square this dilemma with the need to protect refugees?

The clearest argument is that refugees and migrants make huge contributions to society. Most international migrants who are refugees live in urban areas, where their work on the front-lines of health care and hospitality is central to pandemic response and recovery. But just as important, is health’s potential to be a unifying force. In the UK, the Government is reducing the foreign aid budget from 0·7% to 0·5% of gross national income. This decision has prompted not just criticism from humanitarian agencies and opposition parties, but also a recent rebellion from senior members of its own party. What unites them is a basic agreement that policy should not condemn individuals to death or illness. Viewed this way, health becomes an instrument to cut across political divides. In an age when the world faces competing and reinforcing challenges, of climate change, conflict, pandemics, mass forced migration, and polarised political responses, such an instrument could be invaluable.

Polio eradication at the crossroads

Lancet Global Health
Jun 2021 Volume 9 Number 6 e721-e879
https://www.thelancet.com/journals/langlo/issue/current

 

Viewpoint Online First
Polio eradication at the crossroads
Konstantin Chumakov, PhD , Ellie Ehrenfeld, PhD , ., Prof Eckard Wimmer, PhD
Summary
The Global Polio Eradication Initiative, launched in 1988 with anticipated completion by 2000, has yet to reach its ultimate goal. The recent surge of polio cases urgently calls for a reassessment of the programme’s current strategy and a new design for the way forward. We propose that the sustainable protection of the world population against paralytic polio cannot be achieved simply by stopping the circulation of poliovirus but must also include maintaining high rates of population immunity indefinitely, which can be created and maintained by implementing global immunisation programmes with improved poliovirus vaccines that create comprehensive immunity without spawning new virulent viruses. The proposed new strategic goal of eradicating the disease rather than the virus would lead to a sustainable eradication of poliomyelitis while simultaneously promoting immunisation against other vaccine-preventable diseases.

The epidemiological impact of the NHS COVID-19 app

Nature
Volume 594 Issue 7863, 17 June 2021
https://www.nature.com/nature/volumes/594/issues/7863

 

Article | 12 May 2021
The epidemiological impact of the NHS COVID-19 app
Statistical analysis of COVID-19 transmission among users of a smartphone-based digital contact-tracing app suggests that such apps can be an effective measure for reducing disease spread.
Chris Wymant, Luca Ferretti, Christophe Fraser

Integrated vaccination and physical distancing interventions to prevent future COVID-19 waves in Chinese cities

Nature Human Behaviour
Volume 5 Issue 6, June 2021
https://www.nature.com/nathumbehav/volumes/5/issues/6

 

Article | 18 February 2021
Integrated vaccination and physical distancing interventions to prevent future COVID-19 waves in Chinese cities
Vaccination combined with physical distancing can suppress resurgences without relying on stay-at-home restrictions. To achieve herd immunity, cities with a higher population density require more stringent physical distancing measures with longer durations.
Bo Huang, Jionghua Wang, Shengjie Lai

Anti-intellectualism and the mass public’s response to the COVID-19 pandemic

Nature Human Behaviour
Volume 5 Issue 6, June 2021
https://www.nature.com/nathumbehav/volumes/5/issues/6

 

Article | 28 April 2021
Anti-intellectualism and the mass public’s response to the COVID-19 pandemic
Merkley and Loewen find that anti-intellectualism (distrust in experts and intellectuals) is linked to COVID-19 (mis)perceptions, compliance with public health directives and information search using survey and experimental data from Canada.
Eric Merkley, Peter John Loewen

Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries

Nature Medicine
Volume 27 Issue 6, June 2021
https://www.nature.com/nm/volumes/27/issues/6

 

Review Article | 17 May 2021
Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries
A review of COVID-19 responses in 28 selected countries identifies elements of highly effective public health responses and offers recommendations toward strengthening health systems resilience.
Victoria Haldane, Chuan De Foo, Helena Legido-Quigley

COVID-19 dynamics after a national immunization program in Israel

Nature Medicine
Volume 27 Issue 6, June 2021
https://www.nature.com/nm/volumes/27/issues/6

 

Article | 19 April 2021
COVID-19 dynamics after a national immunization program in Israel
A retrospective analysis of data from the Israeli Ministry of Health collected between 28 August 2020 and 24 February 2021 documents the real-life effect of a national vaccination campaign on the pandemic dynamics.
Hagai Rossman, Smadar Shilo, Eran Segal